A Study of Chinese Adults With Lymphoma

NCT05288491 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 934

Last updated 2024-08-12

No results posted yet for this study

Summary

The main aim of this study is to improve methods of clinical testing and therapy for lymphoma participants.

This study will involve collecting information about participants from past medical records.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2024-06-20
Completion
2024-06-20

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05288491 on ClinicalTrials.gov